scispace - formally typeset
G

Gaurav Manohar Rajani

Researcher at MedImmune

Publications -  11
Citations -  755

Gaurav Manohar Rajani is an academic researcher from MedImmune. The author has contributed to research in topics: Adjuvant & Vaccination. The author has an hindex of 7, co-authored 10 publications receiving 547 citations. Previous affiliations of Gaurav Manohar Rajani include Penn State Milton S. Hershey Medical Center.

Papers
More filters
Journal ArticleDOI

Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant.

TL;DR: The findings presented here underscore the need to evaluate a nonlive RSV vaccine candidate during preclinical development over a wide dose range in the cotton rat RSV enhanced-disease model, as suboptimal dosing of several RSV F subunit vaccine candidates led to the priming for ERD.
Journal ArticleDOI

Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants

TL;DR: In vivo studies using the emulsions as an adjuvant with RSV F antigen revealed that superior immunogenicity could be achieved with the 80 nm particle size emulsion.
Journal ArticleDOI

PCPP-Adjuvanted Respiratory Syncytial Virus (RSV) sF Subunit Vaccine: Self-Assembled Supramolecular Complexes Enable Enhanced Immunogenicity and Protection.

TL;DR: It is demonstrated that RSV sF-PCPP formulations induce high neutralization titers to RSV comparable to alum formulations even at a low PCPP dose and protect animals against viral challenge both in the lung and in the upper respiratory tract.